Link between interleukin-10 level and outcome after ischemic stroke

NeuroImmunoModulation

Volumn 17, Issue 4, 2010, Pages 223-228

  Chang, Li Teh ^a   Yuen, Chun Man ^b   Liou, Chia Wei ^c   Lu, Cheng Hsien ^c   Chang, Wen Neng ^c   Youssef, Ali A ^e   Yip, Hon Kan ^d  

^a MEIHO UNIVERSITY   (Taiwan)

^b Department of Surgery   (China)

^c Department of Neurology ^*  (China)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e Suez Canal University Hospital   (Egypt)

Author keywords

Acute coronary syndromes; Cardiovascular diseases; Cerebrovascular diseases; Interleukin 10; Ischemic stroke; Stroke outcome

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; ENCEPHALITIS; FEMALE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECOVERY OF FUNCTION; STROKE; UP-REGULATION;

EID: 77950111031     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000290038     Document Type: Article

References (24)

1. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
2. Ghani U, Shuaib A, Salam A, Nasir A, Shuaib U, Jeerakathil T, et al: Endothelial progenitor cells during cerebrovascular disease. Stroke 2005; 36: 151-153.
3. Chen ZM, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS, et al: Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. On behalf of the CAST and IST collaborative groups. Stroke 2000; 31: 1240-1249.
4. Yip HK, Chen SS, Liu JS, Chang HW, Kao YF, Lan MY, et al: Serial changes in platelet activation in patients after ischemic stroke: role of pharmacodynamic modulation. Stroke 2004; 35: 1683-1687.
5. Hankey GJ: Stroke: how large a public health problem, and how can the neurologist help? Arch Neurol 1999; 56: 748-754.
6. Bonita R, Beaglehole R: Recovery of motor function after stroke. Stroke 1988; 19: 1497-1500.
7. Janeway CA Jr: Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989; 54: 1-13.
8. Tedgui A, Mallat Z: Anti-inflammatory mechanisms in the vascular wall. Circ Res 2001; 88: 877-887.
9. Grutz G: New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol 2005; 77: 3-15.
10. Pinderski LJ, Fischbein MP, Subbanagounder G, Fishbein MC, Kubo N, Cheroutre H, et al: Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ Res 2002; 90: 1064-1071.
11. Nishihira K, Imamura T, Yamashita A, Hatakeyama K, Shibata Y, Nagatomo Y, et al: Increased expression of interleukin-10 in unstable plaque obtained by directional coronary atherectomy. Eur Heart J 2006; 27: 1685-1689.
12. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, et al: Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003; 107: 2109-2114.
13. Yip HK, Youssef AA, Chang LT, Yang CH, Sheu JJ, Chua S, et al: Association of interleukin-10 level with increased 30-day mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. Circ J 2007; 71: 1086-1091.
14. Vila N, Castillo J, Davalos A, Esteve A, Planas AM, Chamorro A: Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 2003; 34: 671-675.
15. Goldstein LB, Bertels C, Davis JN: Interrater reliability of the NIH stroke scale. Arch Neurol 1989; 46: 660-662.
16. Muir KW, Weir CJ, Murray GD, Povey C, Lees KR: Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke 1996; 27: 1817-1820.
17. Yip HK, Liou CW, Chang HW, Lan MY, Liu JS, Chen MC: Link between platelet activity and outcomes after an ischemic stroke. Cerebrovasc Dis 2005; 20: 120-128.
18. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC: Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001; 104: 746-749.
19. Shibata M, Endo S, Inada K, Kuriki S, Harada M, Takino T, et al: Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res 1997; 17: 145-150.
20. Zaremba J, Losy J: Interleukin-18 in acute ischaemic stroke patients. Neurol Sci 2003; 24: 117-124.
21. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, et al: Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol 1997; 110: 492-499.
22. Pelidou SH, Kostulas N, Matusevicius D, Kivisakk P, Kostulas V, Link H: High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases. Eur J Neurol 1999; 6: 437-442.
23. Perini F, Morra M, Alecci M, Galloni E, Marchi M, Toso V: Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol Sci 2001; 22: 289-296.
24. Youssef AA, Chang LT, Hang CL, Wu CJ, Cheng CI, Yang CH, et al: Level and value of interleukin-18 in patients with acute myocardial infarction undergoing primary coronary angioplasty. Circ J 2007; 71: 703-708.